San Leandro, CA, United States of America

Yating Shi

This inventor holds 2 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignee: Life Technologies Corporation. Active years: 2016-2021.

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • San Leadro, CA (US) (2016)
  • San Leandro, CA (US) (2021)

Company Filing History:


Years Active: 2016-2021

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Yating Shi: Innovator in Nucleic Acid Detection

Introduction

Yating Shi is a prominent inventor based in San Leandro, CA (US). She has made significant contributions to the field of nucleic acid synthesis and detection. With a total of 2 patents, her work is recognized for its innovative approaches and practical applications.

Latest Patents

Yating Shi's latest patents focus on compositions, kits, and methods for the synthesis and/or detection of nucleic acids. One of her notable inventions includes a composition comprising a thermostable DNA polymerase and a PCR inhibitor blocking agent. This agent is present in an amount effective to enhance the tolerance of an assembled PCR to a PCR inhibitor. This innovation is crucial for improving the reliability of PCR processes in various applications.

Career Highlights

Yating Shi is currently employed at Life Technologies Corporation, where she continues to advance her research and development efforts. Her work has been instrumental in enhancing the capabilities of nucleic acid detection technologies.

Collaborations

Some of her notable coworkers include Christopher Trinh and Tom Cheng Xu. Their collaborative efforts contribute to the innovative environment at Life Technologies Corporation.

Conclusion

Yating Shi's contributions to the field of nucleic acid detection exemplify her dedication to innovation and research. Her patents reflect her expertise and commitment to advancing scientific knowledge.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…